LADENBURG THALMANN FINANCIAL SERVICES INC. - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 180 filers reported holding NEKTAR THERAPEUTICS in Q2 2016. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q4 2019$704,000
+31.1%
32,667
+10.7%
0.00%0.0%
Q3 2019$537,000
-37.6%
29,501
+21.9%
0.00%
-33.3%
Q2 2019$861,000
+24.4%
24,195
+17.6%
0.01%
+20.0%
Q1 2019$692,000
+17.5%
20,580
+15.0%
0.01%0.0%
Q4 2018$589,000
-44.3%
17,895
+3.3%
0.01%
-44.4%
Q3 2018$1,057,000
-4.7%
17,323
+66.0%
0.01%
-10.0%
Q2 2018$1,109,0000.0%10,4380.0%0.01%0.0%
Q1 2018$1,109,000
+304.7%
10,438
+126.8%
0.01%
+233.3%
Q4 2017$274,000
+185.4%
4,603
+14.4%
0.00%
+200.0%
Q3 2017$96,000
+17.1%
4,025
-3.6%
0.00%0.0%
Q2 2017$82,000
-23.4%
4,175
-8.7%
0.00%0.0%
Q1 2017$107,000
-68.4%
4,575
-83.4%
0.00%
-80.0%
Q4 2016$339,000
+370.8%
27,536
+565.8%
0.01%
+400.0%
Q3 2016$72,000
+53.2%
4,136
+23.6%
0.00%0.0%
Q2 2016$47,000
+2.2%
3,345
+0.8%
0.00%0.0%
Q1 2016$46,000
-41.8%
3,318
-29.3%
0.00%0.0%
Q4 2015$79,000
+5.3%
4,693
-31.2%
0.00%
-50.0%
Q3 2015$75,000
-16.7%
6,818
-4.9%
0.00%0.0%
Q2 2015$90,000
+13.9%
7,1680.0%0.00%0.0%
Q1 2015$79,000
-11.2%
7,168
+24.3%
0.00%0.0%
Q4 2014$89,000
+30.9%
5,768
+3.0%
0.00%0.0%
Q3 2014$68,000
-5.6%
5,6000.0%0.00%0.0%
Q2 2014$72,000
+5.9%
5,6000.0%0.00%0.0%
Q1 2014$68,000
+33.3%
5,600
+24.4%
0.00%0.0%
Q4 2013$51,000
+34.2%
4,500
+25.0%
0.00%
+100.0%
Q3 2013$38,000
+660.0%
3,600
+800.0%
0.00%
Q2 2013$5,0004000.00%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q2 2016
NameSharesValueWeighting ↓
HARVEY CAPITAL MANAGEMENT INC 598,400$10,083,0003.98%
Opus Point Partners Management, LLC 348,583$5,874,0003.88%
Camber Capital Management LP 3,500,000$58,975,0003.81%
1492 Capital Management LLC 180,601$3,043,0002.21%
Virtus ETF Advisers LLC 38,260$645,0001.77%
Cormorant Asset Management, LP 765,156$12,893,0001.54%
Rhenman & Partners Asset Management AB 581,000$9,790,0001.48%
Granahan Investment Management 2,082,155$35,084,0001.21%
BRIDGER MANAGEMENT, LLC 1,563,862$26,351,0000.87%
RICE HALL JAMES & ASSOCIATES, LLC 899,531$15,157,0000.87%
View complete list of NEKTAR THERAPEUTICS shareholders